An integrated view of cisplatin-induced nephrotoxicity and ototoxicity

Takatoshi Karasawa; Peter S. Steyger

doi:10.1016/j.toxlet.2015.06.012

An integrated view of cisplatin-induced nephrotoxicity and ototoxicity

Takatoshi Karasawa, Peter S. Steyger

Research output: Contribution to journal › Review article › peer-review

333 Scopus citations

Abstract

Cisplatin is one of the most widely-used drugs to treat cancers. However, its nephrotoxic and ototoxic side-effects remain major clinical limitations. Recent studies have improved our understanding of the molecular mechanisms of cisplatin-induced nephrotoxicity and ototoxicity. While cisplatin binding to DNA is the major cytotoxic mechanism in proliferating (cancer) cells, nephrotoxicity and ototoxicity appear to result from toxic levels of reactive oxygen species and protein dysregulation within various cellular compartments. In this review, we discuss molecular mechanisms of cisplatin-induced nephrotoxicity and ototoxicity. We also discuss potential clinical strategies to prevent nephrotoxicity and ototoxicity and their current limitations.

Original language	English (US)
Pages (from-to)	219-227
Number of pages	9
Journal	Toxicology Letters
Volume	237
Issue number	3
DOIs	https://doi.org/10.1016/j.toxlet.2015.06.012
State	Published - Sep 7 2015
Externally published	Yes

Keywords

Cisplatin
Intracellular mechanisms
Nephrotoxicity
Ototoxicity

ASJC Scopus subject areas

Toxicology

Access to Document

10.1016/j.toxlet.2015.06.012

Cite this

@article{8e1c4862280d4e1d8d82f4acf3789907,

title = "An integrated view of cisplatin-induced nephrotoxicity and ototoxicity",

abstract = "Cisplatin is one of the most widely-used drugs to treat cancers. However, its nephrotoxic and ototoxic side-effects remain major clinical limitations. Recent studies have improved our understanding of the molecular mechanisms of cisplatin-induced nephrotoxicity and ototoxicity. While cisplatin binding to DNA is the major cytotoxic mechanism in proliferating (cancer) cells, nephrotoxicity and ototoxicity appear to result from toxic levels of reactive oxygen species and protein dysregulation within various cellular compartments. In this review, we discuss molecular mechanisms of cisplatin-induced nephrotoxicity and ototoxicity. We also discuss potential clinical strategies to prevent nephrotoxicity and ototoxicity and their current limitations.",

keywords = "Cisplatin, Intracellular mechanisms, Nephrotoxicity, Ototoxicity",

author = "Takatoshi Karasawa and Steyger, {Peter S.}",

note = "Funding Information: This work was supported by National Institute on Deafness and Other Communication Disorders at the National Institutes of Health (R21 DC010231; R01 DC012588) and Medical Research Foundation of Oregon grants to P.S.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Publisher Copyright: {\textcopyright} 2015 Elsevier Ireland Ltd.",

year = "2015",

month = sep,

day = "7",

doi = "10.1016/j.toxlet.2015.06.012",

language = "English (US)",

volume = "237",

pages = "219--227",

journal = "Toxicology Letters",

issn = "0378-4274",

publisher = "Elsevier BV",

number = "3",

}

TY - JOUR

T1 - An integrated view of cisplatin-induced nephrotoxicity and ototoxicity

AU - Karasawa, Takatoshi

AU - Steyger, Peter S.

N1 - Funding Information: This work was supported by National Institute on Deafness and Other Communication Disorders at the National Institutes of Health (R21 DC010231; R01 DC012588) and Medical Research Foundation of Oregon grants to P.S.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Publisher Copyright: © 2015 Elsevier Ireland Ltd.

PY - 2015/9/7

Y1 - 2015/9/7

N2 - Cisplatin is one of the most widely-used drugs to treat cancers. However, its nephrotoxic and ototoxic side-effects remain major clinical limitations. Recent studies have improved our understanding of the molecular mechanisms of cisplatin-induced nephrotoxicity and ototoxicity. While cisplatin binding to DNA is the major cytotoxic mechanism in proliferating (cancer) cells, nephrotoxicity and ototoxicity appear to result from toxic levels of reactive oxygen species and protein dysregulation within various cellular compartments. In this review, we discuss molecular mechanisms of cisplatin-induced nephrotoxicity and ototoxicity. We also discuss potential clinical strategies to prevent nephrotoxicity and ototoxicity and their current limitations.

AB - Cisplatin is one of the most widely-used drugs to treat cancers. However, its nephrotoxic and ototoxic side-effects remain major clinical limitations. Recent studies have improved our understanding of the molecular mechanisms of cisplatin-induced nephrotoxicity and ototoxicity. While cisplatin binding to DNA is the major cytotoxic mechanism in proliferating (cancer) cells, nephrotoxicity and ototoxicity appear to result from toxic levels of reactive oxygen species and protein dysregulation within various cellular compartments. In this review, we discuss molecular mechanisms of cisplatin-induced nephrotoxicity and ototoxicity. We also discuss potential clinical strategies to prevent nephrotoxicity and ototoxicity and their current limitations.

KW - Cisplatin

KW - Intracellular mechanisms

KW - Nephrotoxicity

KW - Ototoxicity

UR - http://www.scopus.com/inward/record.url?scp=84934764055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84934764055&partnerID=8YFLogxK

U2 - 10.1016/j.toxlet.2015.06.012

DO - 10.1016/j.toxlet.2015.06.012

M3 - Review article

C2 - 26101797

AN - SCOPUS:84934764055

SN - 0378-4274

VL - 237

SP - 219

EP - 227

JO - Toxicology Letters

JF - Toxicology Letters

IS - 3

ER -

An integrated view of cisplatin-induced nephrotoxicity and ototoxicity

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this